Loureirin B

Loureirin B is an inhibitor of Calcium Channels and Potassium Channels and related targets used in studies of MAPK / ERK Signaling and TGF-beta / Smad Signaling and related signaling programs. In practice, this places the compound in experiments that measure mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and Smad-mediated transcription, differentiation, and fibrotic signaling in cancer, cardiovascular, and cell signaling models.

By inhibiting Calcium Channels and Potassium Channels and related targets, Loureirin B can be used to examine mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and Smad-mediated transcription, differentiation, and fibrotic signaling. The ion channel annotation adds relevance to electrophysiology, ion-flux, and membrane-potential studies, together with downstream-response mapping in the same experimental setting. In cancer, cardiovascular, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Calcium Channels and Potassium Channels and related targets
• Pathway perturbation studies connected to MAPK / ERK Signaling and TGF-beta / Smad Signaling and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Electrophysiology, ion-flux, and membrane-potential studies

Overall, Loureirin B is appropriate when a defined chemical perturbant is needed to connect Calcium Channels and Potassium Channels and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cardiovascular, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.